Overweight, Chronic Low Back Pain (CLBP), Obesity research hub

J1I-MC-GZQD: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly in Participants Who Have Obesity or Overweight and Chronic Low Back Pain (TRIUMPH-7)

This study is looking at a new medicine called Retatrutide for people who are overweight or have obesity and suffer from ongoing lower back pain. It compares the new medicine to a dummy treatment (placebo) to see if it helps with pain and weight over 72 weeks.